Novel candidates for chronic diabetic wound healing

Authors

  • Muhammad Shakil Khan COMSATS University Islamabad
  • Tauqeer Ahmed Malik Islamabad Diabetic Foot Center (IDFC), E-11/2, Shah Tower, Islamabad, Pakistan

DOI:

https://doi.org/10.66344/jpad.32.3.2022.1923

Abstract

Diabetic Foot Ulcer (DFU) is a leading cause of amputation in adult population all over the world. Molecular pathology of delay in wound healing of diabetic foot ulcer patient is not completely understood till today. Numerous works has been required to explore the cause of delay in wound healing which ultimately end in amputation. To find the role of long non-coding RNAs is a promising strategy which could be beneficial in treating the chronic wound timely and progressively. We have selected long non-coding RNAs (ANRIL and its target miR-181a, H19 and its target miR-29b) which are involved in the inflammation, proliferation and remodeling phase of wound healing process and do comparison of their expression in DFU patients and normal healthy individuals. Our results revealed that ANRIL down regulation and H19 up regulation in DFU patients and similarly miR-181a up regulation and miR-29b down regulation. These results needed further validation by sequencing work therefore these can be used as diagnostic marker for an early detection in diabetic patients to halt the progression of DFU wound healing delay. Keywords: Diabetic Foot Ulcer; amputation; long non-coding RNAs

Author Biography

Tauqeer Ahmed Malik, Islamabad Diabetic Foot Center (IDFC), E-11/2, Shah Tower, Islamabad, Pakistan

CEO/ Director

Downloads

Published

2022-08-27

How to Cite

1.
Khan MS, Tauqeer Ahmed Malik. Novel candidates for chronic diabetic wound healing. J Pak Assoc Dermatol [Internet]. 2022Aug.27 [cited 2026Apr.22];32(3):526-31. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1923

Issue

Vol. 32 No. 3 (2022): July - September

Section

Original Articles

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.